
Surgery
Surgery is the main treatment for most localised uterine sarcomas. A total hysterectomy removes the uterus and cervix. The aim is to remove the tumour completely and intact without cutting or disrupting it.

From diagnosis and treatment planning to surgery, recovery and long-term follow-up, experience care that considers your strength, nutrition, hormonal health, comfort and overall wellbeing.

A diagnosis can bring many questions at once. Let us begin with the basics.
Uterine sarcoma is a rare cancer that develops in the muscle or supporting tissues of the uterus. It differs from endometrial cancer, which begins in the uterine lining and is much more common. Major types include uterine leiomyosarcoma, low-grade and high-grade endometrial stromal sarcoma, undifferentiated uterine sarcoma and uterine adenosarcoma. Rare molecularly defined sarcomas can also occur. Symptoms may include abnormal vaginal bleeding, pelvic or abdominal pain or pressure, a pelvic mass or increasing abdominal size. Leiomyosarcoma can sometimes resemble a benign fibroid on imaging. The exact tumour type, stage, molecular features and specialist pathology findings are important for determining the most appropriate treatment approach.
Treatment should ideally be planned by a team experienced in both gynaecologic oncology and sarcoma because management differs considerably between subtypes.

Cancer Healer Therapy (CAM) is supportive integrative care used alongside treatment prescribed by your gynaecologic and sarcoma oncology team, not instead of it.
The supportive plan may consider appetite, fatigue, sleep, emotional wellbeing, recovery after surgery and treatment-related discomfort.
Herbal medicines and supplements can interact with chemotherapy, hormone therapy, targeted medicines, blood thinners and surgical medicines.
Products marketed as supporting oestrogen or balancing female hormones may be particularly unsuitable for hormone-sensitive uterine sarcomas.
Support may begin before surgery, chemotherapy, hormone treatment or radiation, with attention to bleeding, pelvic symptoms, nutrition, organ function and current medicines.
Rare molecularly defined tumours, including NTRK-rearranged sarcomas, may have specific targeted treatment options in advanced disease.


Here’s exactly what happens from your first conversation with us to ongoing support during treatment.
We discuss your diagnosis, pathology, scans, symptoms and current or planned treatment.
The team reviews the exact sarcoma subtype, stage, tumour size, margins, whether morcellation occurred, hormone receptors and molecular findings.
Supportive care is developed around your surgery, systemic treatment or surveillance plan.
Herbal products, supplements and special diets should be disclosed to your treating oncology team.
The plan may be reviewed as symptoms, imaging, organ function and treatment needs change.
One point of contact supports appointments and follow-up communication.

Meet Dr. Tarang Krishna, MD - Cancer Healer Center
Dr. Tarang Krishna has spent over two decades developing and refining Cancer Healer Therapy, working with a multidisciplinary team across 30+ centres in India.
His work has been recognised for innovative cancer care and brings a coordinated, supportive approach to every patient journey.

Every cancer journey is personal. Read experiences shared by patients and families about the consultations, communication, follow-up and support they received at Cancer Healer Center.
4.9 Stars | 5479 Reviews
No. Endometrial cancer begins in the uterine lining. Uterine sarcoma begins in muscle or supporting tissues and has different treatment pathways.